Australian Pancreatic Cancer Genome Initiative

The APGI mission is to accelerate the translation of scientific discoveries to improve outcomes for pancreatic cancer patients.

The Australian Pancreatic Cancer Genome Initiative (APGI) is a global research enterprise of over 100 scientists, clinicians and allied health professionals involved in pancreatic cancer research and care. The APGI has mapped the genome of pancreatic cancer in a landmark effort as part of Australia’s contribution to the International Cancer Genome Consortium (ICGC). This fundamental understanding of the genetic underpinnings of Pancreatic Cancer is accelerating the evolution of pancreatic cancer care into the molecular age of oncology. The APGI’s world-class BioResource –  biological samples coupled with comprehensive clinical and genomic data – is aiding research worldwide in ongoing discovery and development through quality research and strategic collaborations.

In the News

Pancreatic cancer: a lucky quirk in Ros’ DNA holds the key to survival - Nov 14, 2017
Long-term survivors of pancreatic cancer have ‘built-in immunotherapy’ - Nov 09, 2017
The importance of returning research results to study participants - Oct 10, 2017
NSW Government funding for Garvan scientists to research new treatments for breast and pancreatic cancer - Feb 17, 2017
The ‘other’ pancreatic cancer: uncovering the genomic landscape of an enigmatic rare tumour - Feb 16, 2017
NHMRC funding success for Garvan researchers - Nov 09, 2015
New alliance gives a united voice to pancreatic cancer - Oct 28, 2015
Throwing light on how to conduct a personalised pancreas cancer clinical trial - Apr 20, 2015
How the landscape of the pancreatic cancer genome is coming into view - Feb 26, 2015
Early detection window when pancreatic cancer is in the family - Oct 15, 2014
Large-scale pancreatic genome study generates evidence for important ethical debate - Jun 20, 2014
Aussie generosity still vital following medical future fund announcement - Jun 06, 2014
Potential treatment for a specific kind of pancreatic cancer - Sep 16, 2013
International team reveals 21 ‘signatures’ in 30 common cancers - Aug 15, 2013
Unmasking the deadly secrets of pancreatic cancer - Oct 25, 2012
Pancreatic Cancer Research Group wins Cancer Institute NSW award - Jul 30, 2012
Helping pancreatic cancer surgeons make tiebreaker decisions - Apr 15, 2011
Personalised medicine for cancer patients in a new technology era - Apr 15, 2010
Emily Colvin wins Premier’s Award for Outstanding Cancer Research Scholar - May 27, 2009
Garvan to play a role in International Cancer Genome Consortium - Mar 26, 2009

Loading jobs...